Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Long-Term Investments (2018 - 2023)

Updated

Rocket Pharmaceuticals (RCKT) recorded Long-Term Investments of $34.32 million in Q4 2023, down 20.7% from $43.28 million a year earlier.

Analysis

Rocket Pharmaceuticals (RCKT) Long-Term Investments (2018 - 2023) Analysis & Trends

Starting with Q2 2018, Rocket Pharmaceuticals' Long-Term Investments history includes 6 quarters.

  • Annual Long-Term Investments has a five-year compound annual growth rate of 35.9% (FY2018 to FY2023).
  • Across earlier years, Long-Term Investments came in at $43.28 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 34.32 Mn
Mar 31, 2023 28.96 Mn
Dec 31, 2022 43.28 Mn
Dec 31, 2018 7.40 Mn
Sep 30, 2018 32.00 Mn
Jun 30, 2018 39.36 Mn
API Access

Rocket Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RCKT&period=max&api_key=YOUR_API_KEY